Experience New Benchmarks Building upon 40 years of experience in LC technology, the Nexera series is a family of UHPLC systems that marries these AI and IoT enhancements to set new industry standards in terms of intelligence, efficiency, and design.
Solutions for COVID-19 Drug Analysis
Shimadzu offers a series of application notes exploring the latest and most up-to-date solutions for COVID-19 drug analysis. Read more below to learn how Shimadzu can meet your COVID-19 drug analysis needs.
Application of HPLC in Quality Analysis of Hydroxychloroquine Sulfate
In this study, methods were established for analysis of hydroxychloroquine sulfate and related substances following European Pharmacopoeia (EP10.0) and for determination of hydroxychloroquine sulfate content in tablet following US Pharmacopoeia (USP 43)
Determination of Hydroxychloroquine Concentration in Human Plasma by LC-MS/MS Method
This study provides a method for quantitative analysis of hydroxychloroquine (HCQ) in human plasma using Shimadzu ultra high performance liquid chromatography coupled with triple quadrupole mass spectrometry (UHPLC-MS/MS; Nexera with LCMS-8050)…
Continuing the evolution of Shimadzu's UF technology, the LCMS-8050 triple quadrupole mass spectrometer offering unparalleled measurement speeds and high-sensitivity performance. The measurements can now be performed even faster, without sacrificing data quality. At the same time, more compounds can now be measured in simultaneous qualitative and quantitative analysis.